- Home
- SIEB vs SRZN Comparison
SIEB vs SRZN Comparison
Compare SIEB & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIEB
- SRZN
- Stock Information
- Founded
- SIEB 1886
- SRZN 2015
- Country
- SIEB United States
- SRZN United States
- Employees
- SIEB N/A
- SRZN N/A
- Industry
- SIEB Investment Bankers/Brokers/Service
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- SIEB Finance
- SRZN Health Care
- Exchange
- SIEB Nasdaq
- SRZN Nasdaq
- Market Cap
- SIEB 126.1M
- SRZN 120.0M
- IPO Year
- SIEB N/A
- SRZN N/A
- Fundamental
- Price
- SIEB $2.90
- SRZN $13.75
- Analyst Decision
- SIEB
- SRZN Strong Buy
- Analyst Count
- SIEB 0
- SRZN 2
- Target Price
- SIEB N/A
- SRZN $38.50
- AVG Volume (30 Days)
- SIEB 17.7K
- SRZN 84.2K
- Earning Date
- SIEB 11-12-2025
- SRZN 11-07-2025
- Dividend Yield
- SIEB N/A
- SRZN N/A
- EPS Growth
- SIEB N/A
- SRZN N/A
- EPS
- SIEB 0.18
- SRZN N/A
- Revenue
- SIEB $90,289,000.00
- SRZN $3,604,000.00
- Revenue This Year
- SIEB N/A
- SRZN N/A
- Revenue Next Year
- SIEB N/A
- SRZN N/A
- P/E Ratio
- SIEB $16.05
- SRZN N/A
- Revenue Growth
- SIEB 8.32
- SRZN N/A
- 52 Week Low
- SIEB $2.08
- SRZN $5.90
- 52 Week High
- SIEB $5.77
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- SIEB 47.81
- SRZN 58.65
- Support Level
- SIEB $2.70
- SRZN $12.12
- Resistance Level
- SIEB $2.91
- SRZN $13.31
- Average True Range (ATR)
- SIEB 0.17
- SRZN 0.89
- MACD
- SIEB 0.01
- SRZN 0.05
- Stochastic Oscillator
- SIEB 67.54
- SRZN 81.61
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).